Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
58.73
-0.99 (-1.66%)
At close: Apr 28, 2026, 4:00 PM EDT
58.17
-0.56 (-0.95%)
After-hours: Apr 28, 2026, 5:29 PM EDT
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$1,512,087
Market Cap
8.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 925 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
PCVX News
- 14 days ago - Vaxcyte Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 21 days ago - Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults - GlobeNewsWire
- 5 weeks ago - Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate - GlobeNewsWire
- 7 weeks ago - Vaxcyte Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Vaxcyte Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Vaxcyte Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire